Autoantibody response to a novel tumor-associated antigen p90/CIP2A in breast cancer immunodiagnosis.
Autoantibody response to a novel tumor-associated antigen p90/CIP2A in breast cancer immunodiagnosis.
复制标题
乳腺癌免疫诊断中对新型肿瘤相关抗原 p90/CIP2A 的自身抗体反应
DOI:
10.1007/s13277-013-1350-6
复制
发表时间:
2014-03
期刊:
影响因子:
--
通讯作者:
Zhang, Jian-Ying
中科院分区:
文献类型:
--
作者:
Liu, Xinxin;Chai, Yurong;Li, Jitian;Ren, Pengfei;Liu, Mei;Dai, Liping;Qian, Wei;Li, Wenjie;Zhang, Jian-Ying
There is an urgent need to identify relevant tumor markers showing high sensitivity and specificity for early immunodiagnosis of breast cancer. Autoantibodies directed against tumor-associated antigens (TAAs) have been shown to be relevant tumor markers. The purpose of this study was to evaluate whether autoantibodies to a tumor-associated antigen p90/CIP2A can be used as diagnostic markers in breast cancer. In this study, autoantibody responses to p90/CIP2A were evaluated by enzyme-linked immunosorbent assay (ELISA), western blotting, and indirect immunofluorescence assay in sera from patients with breast cancer and normal human individuals. The results have demonstrated that p90/CIP2A can induce a relatively higher frequency of autoantibody response in breast cancer (19.1 %) compared to the sera of normal individuals (2.3 %). The frequency of p90/CIP2A expression in breast cancer tissues was significantly higher than that in adjacent normal tissues (P <0.01). Our preliminary results suggest that autoantibodies against p90/CIP2A may be a useful serum biomarker for early stage breast cancer screening and diagnosis.
登录
查看更多内容
影响因子:
11.5
作者:
Come, Christophe;Laine, Anni;Westermarck, Jukka
通讯作者:
Westermarck, Jukka
影响因子:
3.3
作者:
Desmetz, C.;Cortijo, C.;Solassol, J.
通讯作者:
Solassol, J.
影响因子:
3.7
作者:
Dong, Qian-Ze;Wang, Yang;Wang, En-Hua
通讯作者:
Wang, En-Hua
影响因子:
10.3
作者:
Khanna, Anchit;Bockelman, Camilla;Ristimaki, Ari
通讯作者:
Ristimaki, Ari
影响因子:
8
作者:
Chen, K-F;Liu, C-Y;Cheng, A-L
通讯作者:
Cheng, A-L